NGS-based RNA-Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers RNA Sequencing Companies and it is Segmented by Product and Services (Sequencing Platform and Consumables and Sequencing Services), Technology (Nanopore Sequencing, Sequencing by Synthesis, Ion Semiconductor Sequencing and Single-Molecule Real-Time Sequencing), Application (Drug Discovery, Diagnostics, Precision Medicine and Others), End User (Biotechnology and Pharmaceutical Companies, Hospitals, and Clinics, Others) Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

NGS-based RNA-Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

NGS-based RNA-Sequencing Industry Overview

The NGS-based RNA-sequencing market is moderately competitive with several players across the globe. In terms of market share, various major players currently dominate the market. With the increase in research and development activity, many regional players are expected to be part of the NGS-Based RNA-Sequencing Market over the forecast period. Some of the major players in the market are Illumina, Inc.; Oxford Nanopore Technologies; Agilent Technologies, Inc.; Thermo Fisher Scientific, Inc.; PerkinElmer, Inc.; F. Hoffmann-La Roche Ltd.; Hamilton Company; and Takara Bio, Inc., among others.

NGS-based RNA-Sequencing Market Leaders

  1. Illumina, Inc.

  2. Oxford Nanopore Technologies

  3. Agilent Technologies, Inc.

  4. Thermo Fisher Scientific Inc.

  5. PerkinElmer, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
NGS-based RNA Sequencing Market - cl.png